Quality Control, Biosecurity & FDA Standards
Regulatory framework, quality assurance, and institutional requirements for medicinal leech use
March 14, 2026
Medicinal leeches are regulated as FDA 510(k)-cleared medical devices under 21 CFR Part 820, requiring compliance with the Quality Management System Regulation (QMSR, effective February 2, 2026; formerly QSR), 510(k) premarket notification, and current Good Manufacturing Practices (cGMP) aligned with ISO 13485:2016.
FDA Regulatory Framework
| Parameter | Detail |
|---|---|
| Device Classification | Pre-Amendment (510(k) Required) |
| Product Code | NRN (Leech, Medicinal) |
| Regulation Number | 21 CFR Part 820 (QMSR, eff. Feb 2026) |
| 510(k) Clearances | K040187 (2004, Ricarimpex), K132958 (2014, Biopharm), K140907 (2015, Carolina Biological Supply Co.) |
| Cleared Indication | Venous congestion in tissue flaps |
Quality Requirements
Species Identification
COI barcoding (cytochrome c oxidase subunit I) is the standard method for species verification. This molecular identification ensures the correct species (H. medicinalis or H. verbana) is supplied, as morphological identification alone is unreliable between closely related species.
Health Screening
Leeches must be screened for pathogen loads beyond the normal microbiome. The Aeromonas symbiont is expected and unavoidable, but additional bacterial or parasitic infections indicate compromised stock. Activity level, feeding response, and body condition are assessed.
Size & Activity Standards
Medical-grade leeches must meet minimum size requirements (typically 2-5g body weight), demonstrate vigorous swimming behavior, and show strong feeding response. Lethargic or underweight specimens are rejected.
Storage & Transport
Leeches must be maintained at 5-20°C in dechlorinated water during transport and hospital storage. Overnight shipping with temperature control is standard. Hospital pharmacies typically maintain small stocks (10-20 leeches) with regular resupply.
Institutional Requirements
Hospitals using medicinal leeches must establish protocols addressing procurement, storage, application, and disposal within their existing medical device governance frameworks.
| Area | Requirement | Responsible |
|---|---|---|
| Procurement | FDA-cleared supplier only, purchase orders | Pharmacy / Supply Chain |
| Chain of Custody | Lot tracking, receipt documentation | Pharmacy |
| Storage | Temperature-controlled water, daily checks | Pharmacy / Nursing |
| Application | Trained staff, documented protocol | Nursing / Surgical team |
| Disposal | Single-use, biohazard waste container | Nursing / Environmental Services |
Biosecurity
Medicinal leeches pose biosecurity concerns as potential invasive species. Facilities must implement escape prevention measures including secure containers with tight-fitting lids, dedicated storage areas, and protocols for accounting for all leeches before and after clinical use. Post-receipt quarantine (24-48 hours minimum) allows observation for disease, transportation stress recovery, and verification of feeding readiness.